With an integrated, global safety team of over 2,700 across 20 delivery centers, we provide end-to-end safety solutions that span the entire product life cycle of drugs, medical devices, combination products and vaccines from clinical phases through commercialization.

Labcorp Drug Development continues to support the full-service agreement with ongoing recruitment, data management, biostatistics and clinical studies reports following an integrated project schedule.

Imagine getting a phone call in the middle of your study from a scientist who is seeing something completely unexpected in your study results. You need to make a decision on how to move forward and you need to do it quickly. You don't have time to wait for a shipment of glass pathology slides.

Driving study completion in a cardiovascular outcome trial (CVOT) requires extensive planning from the onset to prevent costly errors from remediation, avoid prolonged enrollment periods and minimize delayed or reduced event occurrence.

In this booklet, you will find requirements described in the ISO 14155:2020.

SETAC EU 2022 -- The OECD 229 Test Guideline (Fish Short-Term Reproduction Assay) requires daily assessment of reproduction as one of the measurements of test item effect for potential endocrine disruption. The requirement is for a daily egg production at least 10 eggs per female per day in the control.

SETAC EU 2022 -- Microplastics are small pieces of plastic that pollute the environment. Microplastics are not a specific type of plastic, but rather any plastic fragment that is less than 5 mm in size. They enter the environment via many sources, including cosmetics, clothing, paints and industrial processes.

SETAC-EU 2022 -- The European Chemicals Agency (ECHA) is responsible for implementing the European Union's chemicals legislation. This is designed to ensure the safe use of chemicals while protecting human health and the environment.

ASGCT 2022 -- Cancer immunotherapies reprogram the patient's immune system to mount a coordinated response against a malignant target. T cells engineered to express Chimeric Antigen Receptors (CARs) represent an effective strategy to target specific cancer cells.